Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment

Abstract

Treatment with low-molecular-weight heparins is very common in clinical practice. Exceptionally, some patients develop hepatitis within a few days of starting treatment, and rapid discontinuation of the drug is decisive to avoid chronification.

Keywords

• cholestasis
• enoxaparin
• hepatitis
• toxicity
• transaminases